Your browser doesn't support javascript.
loading
Targeting novel structural and functional features of coronavirus protease nsp5 (3CLpro, Mpro) in the age of COVID-19.
Roe, Molly K; Junod, Nathan A; Young, Audrey R; Beachboard, Dia C; Stobart, Christopher C.
Afiliação
  • Roe MK; Department of Biological Sciences, Butler University, Indianapolis, IN, USA.
  • Junod NA; Department of Biological Sciences, Butler University, Indianapolis, IN, USA.
  • Young AR; Department of Biological Sciences, Butler University, Indianapolis, IN, USA.
  • Beachboard DC; Department of Biology, DeSales University, Center Valley, PA, USA.
  • Stobart CC; Department of Biological Sciences, Butler University, Indianapolis, IN, USA.
J Gen Virol ; 102(3)2021 03.
Article em En | MEDLINE | ID: mdl-33507143
Coronavirus protease nsp5 (Mpro, 3CLpro) remains a primary target for coronavirus therapeutics due to its indispensable and conserved role in the proteolytic processing of the viral replicase polyproteins. In this review, we discuss the diversity of known coronaviruses, the role of nsp5 in coronavirus biology, and the structure and function of this protease across the diversity of known coronaviruses, and evaluate past and present efforts to develop inhibitors to the nsp5 protease with a particular emphasis on new and mostly unexplored potential targets of inhibition. With the recent emergence of pandemic SARS-CoV-2, this review provides novel and potentially innovative strategies and directions to develop effective therapeutics against the coronavirus protease nsp5.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Proteínas não Estruturais Virais / Inibidores de Protease Viral / Proteases 3C de Coronavírus / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Proteínas não Estruturais Virais / Inibidores de Protease Viral / Proteases 3C de Coronavírus / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article